![Charles Osborne](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Charles Osborne
Director of Finance/CFO at
POLAREAN IMAGING PLC
Net worth: 10 332 $ as of 31/01/2026
Profile
Charles Fremont Osborne is currently Chief Financial Officer & Executive Director at Polarean Imaging Plc since 2021, with employment at the firm starting in 2019.
Formerly, the roles include Vice President-Finance at International Murex Technologies Corp., Chief Financial Officer at SCYNEXIS, Inc. from 2003 to 2015, Chief Financial Officer at Nobex Corp., and Chief Financial Officer & Secretary at Innocrin Pharmaceuticals, Inc. from 2015 to 2019.
Education includes an undergraduate degree from The University of North Carolina at Charlotte, conferred in 1987.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 31/12/2024 | 9,656,262 ( 0.8% ) | 10 332 $ | 31/01/2026 |
Charles Osborne active positions
| Companies | Position | Start |
|---|---|---|
| POLAREAN IMAGING PLC | Director of Finance/CFO | 29/04/2019 |
Former positions of Charles Osborne
| Companies | Position | End |
|---|---|---|
Innocrin Pharmaceuticals, Inc.
 Innocrin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops oral inhibitors for the treatment of castration-resistant prostate cancer | Director of Finance/CFO | 01/04/2019 |
| SCYNEXIS, INC. | Director of Finance/CFO | 30/06/2015 |
International Murex Technologies Corp.
 International Murex Technologies Corp. Medical SpecialtiesHealth Technology Develops medical diagnostic products | Director of Finance/CFO | - |
Nobex Corp.
 Nobex Corp. Pharmaceuticals: MajorHealth Technology Provides drug delivery to pharmaceutical industry | Director of Finance/CFO | - |
Training of Charles Osborne
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
52
1st degree connections
6
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
International Murex Technologies Corp.
International Murex Technologies Corp. Medical SpecialtiesHealth Technology Develops medical diagnostic products | Health Technology |
SCYNEXIS, Inc.
 SCYNEXIS, Inc. Pharmaceuticals: MajorHealth Technology Develops novel oral and intravenous triterpenoid antifungal for the treatment of several serious fungal infections | Health Technology |
Nobex Corp.
Nobex Corp. Pharmaceuticals: MajorHealth Technology Provides drug delivery to pharmaceutical industry | Health Technology |
The University of North Carolina at Charlotte
 The University of North Carolina at Charlotte Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Innocrin Pharmaceuticals, Inc.
Innocrin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops oral inhibitors for the treatment of castration-resistant prostate cancer | Health Technology |
Polarean Imaging Plc
 Polarean Imaging Plc Medical SpecialtiesHealth Technology Designs, manufactures and sells noble gas polarizer devices & ancillary instruments | Health Technology |
- Stock Market
- Insiders
- Charles Osborne
